Novacyt H1 Loss Narrows As Revenue Rises 18%
(RTTNews) - Novacyt S.A. (NCYT.L), a diagnostics company providing molecular testing technologies and services, reported higher revenue and a narrower loss for the six months ended June 30, 2026.
Sunday, 22 November 2026
Global markets, trading & world business — for professional traders
Trading
Private Trade News trader edition (2026-10-01): Novacyt H1 Loss Narrows As Revenue Rises 18% (RTTNews) - Novacyt S.A. (NCYT.L), a diagnostics company providing molecular testing technologies and services,… Primary source: original at Nasdaq Market Structure (nasdaq.com).
Novacyt H1 Loss Narrows As Revenue Rises 18%
(RTTNews) - Novacyt S.A. (NCYT.L), a diagnostics company providing molecular testing technologies and services, reported higher revenue and a narrower loss for the six months ended June 30, 2026.